Combination tumor immunotherapy with radiotherapy and Th1 cell therapy against murine lung carcinoma.

Combination tumor immunotherapy with radiotherapy and Th1 cell therapy against murine lung carcinoma. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Combination tumor immunotherapy with radiotherapy and Th1 cell therapy against murine lung carcinoma. Abstract Text:

Hiroshi Yokouchi,Kenji Chamoto,Daiko Wakita,Koichi Yamazaki,Hiroki Shirato,Tsuguhide Takeshima,Hirotoshi Dosaka-Akita,Masaharu Nishimura,Zhang Yue,Hidemitsu Kitamura,Takashi Nishimura,Hiroshi Yokouchi,Kenji Chamoto,Daiko Wakita,Koichi Yamazaki,Hiroki Shirato,Tsuguhide Takeshima,Hirotoshi Dosaka-Akita,Masaharu Nishimura,Zhang Yue,Hidemitsu Kitamura,Takashi Nishimura,Hiroshi Yokouchi,Kenji Chamoto,Daiko Wakita,Koichi Yamazaki,Hiroki Shirato,Tsuguhide Takeshima,Hirotoshi Dosaka-Akita,Masaharu Nishimura,Zhang Yue,Hidemitsu Kitamura,Takashi Nishimura,

Mice bearing established Lewis lung carcinoma (LLC) expressing model tumor antigen, ovalbumin (OVA) (LLC-OVA) marginally responded to local radiotherapy, but none of the mice was cured. In contrast, treatment of the tumor-bearing mice with intratumoral injection of tumor-specific T helper type 1 (Th1) cells and tumor antigen (OVA) after radiotherapy dramatically prolonged the survival days and induced complete cure of the mice at high frequency (80%). Radiation therapy combined with Th1 cells or OVA alone showed no significant therapeutic activity against LLC-OVA. Such a strong therapeutic activity was not induced by intratumoral injection of Th1 cells plus OVA. Compared with other treatment, radiation therapy combined with Th1 cells and OVA was superior to induce the generation of OVA/H-2(b) tetramer(+) tumor-specific cytotoxic T lymphocyte (CTL) with a strong cytotoxicity against LLC-OVA in draining lymph node (DLN). Moreover, the combined therapy is demonstrated to inhibit the growth of tumor mass, which grew at contralateral side. These results indicated that radiotherapy combined with Th1 cell/vaccine therapy induced a systemic antitumor immunity. These findings suggested that combination therapy with radiotherapy and Th1 cell/vaccine therapy may become a practical strategy for cancer treatment.

Combination tumor immunotherapy with radiotherapy and Th1 cell therapy against murine lung carcinoma. Publishing Authors By Initials

H Yokouchi,K Chamoto,D Wakita,K Yamazaki,H Shirato,T Takeshima,H Dosaka-Akita,M Nishimura,Z Yue,H Kitamura,T Nishimura,H Yokouchi,K Chamoto,D Wakita,K Yamazaki,H Shirato,T Takeshima,H Dosaka-Akita,M Nishimura,Z Yue,H Kitamura,T Nishimura,H Yokouchi,K Chamoto,D Wakita,K Yamazaki,H Shirato,T Takeshima,H Dosaka-Akita,M Nishimura,Z Yue,H Kitamura,T Nishimura,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Combination tumor immunotherapy with radiotherapy and Th1 cell therapy against murine lung carcinoma. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Clinical & experimental metastasis

VOLUME: 24

Page Numbers: 533-40

Journal Abbreviation: Clin. Exp. Metastasis

ISSN: 0262-0898

DAY: 25

MONTH: 07

YEAR: 2007

Combination tumor immunotherapy with radiotherapy and Th1 cell therapy against murine lung carcinoma. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8409970

Combination tumor immunotherapy with radiotherapy and Th1 cell therapy against murine lung carcinoma. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Combination tumor immunotherapy with radiotherapy and Th1 cell therapy against murine lung carcinoma. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Combination tumor immunotherapy with radiotherapy and Th1 cell therapy against murine lung carcinoma.

AFFILIATION: Division of Immunoregulation, Section of Disease Control, Institute for Genetic Medicine, Hokkaido University, N-15, W-7, Kita-ku, Sapporo, 060-0815, Japan, tak24@igm.hokudai.ac.jp.

Country: Netherlands

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Clin Exp Metastasis

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Combination tumor immunotherapy with radiotherapy and Th1 cell therapy against murine lung carcinoma Related Publications

• A New Phenolic Glucoside, Curculigoside from Rhizomes of Curculigo orchioides.
• Action of ascorbic acid on a myosin molecule derived from carp.
• Alginate hydrogel linked with synthetic oligopeptide derived from BMP-2 allows ectopic osteoinduction in vivo.
• Analysis of N-glycan in serum glycoproteins from db/db mice and humans with type 2 diabetes.
• Arteriovenous malformation of the gallbladder: CT and angiographic findings.
• Combination tumor immunotherapy with radiotherapy and Th1 cell therapy against murine lung carcinoma.
• Continence care for older people.
• Dynamic memorization characteristics in neural networks with different neuronal dynamics.
• Evolution of life-history traits collapses competitive coexistence.
• Fluid-attenuated inversion-recovery SSFP imaging.
• Hemodynamics of ovarian veins: MR angiography in women with uterine leiomyomata.
• High glucose up-regulates lipopolysaccharide-stimulated inflammatory cytokine production via c-jun N-terminal kinase in the monocytic cell line THP-1.
• High peak inspiratory flow can aggravate ventilator-induced lung injury in rabbits.
• Influence of human CD8 on antigen recognition by T-cell receptor-transduced cells.
• Knockout of glutelin genes which form a tandem array with a high level of homology in rice by gamma irradiation.
• Management of urethral hemangiomas associated with Klippel-Trenaunay-Weber syndrome by endoscopic sclerotherapy.
• Multitensor tractography enables better depiction of motor pathways: initial clinical experience using diffusion-weighted MR imaging with standard b-value.
• PET measurement of FK506 concentration in a monkey model of stroke.
• Pharmacokinetics of telithromycin using bronchoscopic microsampling after single and multiple oral doses.
• Pitfall of percutaneous cardiopulmonary support for acute massive pulmonary embolism.
• Polarization of Healpha radiation due to anisotropy of fast-electron transport in ultraintense-laser-produced plasmas.
• Randomized placebo-controlled trial of interferon alpha-2b plus ribavirin with and without lactoferrin for chronic hepatitis C.
• Resilience, family adversity and well-being among Hawaiian and non-Hawaiian adolescents.
• Short term prediction of Ht value using BPNN during LCAP.
• Some characteristics of fluoride-induced cell death in rat thymocytes: cytotoxicity of sodium fluoride.
• Sternum fracture and haemorrhage after cardiopulmonary resuscitation.
• T cell immunotherapy.
• Three-dimensional bone-implant integration profiling using micro-computed tomography.
• Tumour necrosis factor alpha production by polymorphonuclear neutrophils treated with mouse anti-human CD19 monoclonal antibody.
• [Recent progress in paroxysmal nocturnal hemoglobinuria]